Home            Past Issues            About IP            About IAP           Author Information            Subscription            Advertisement              Search  

   
correspondence

Indian Pediatr 2010;47: 814

ASV in a Neonate


S Shanthi,

Reader in Pediatrics, Pediatric Intensive Care Unit, Institute of Child Health, Chennai 8, India.
Email: [email protected]
 

I would like to make a few comments regarding a recent article(1). The current recommendation for neurotoxic envenomation irrespective of age is to administer an initial dose of 10 vials of ASV over one hour. A trial of neostigmine is then given and the child is monitored. A second and final dose of 10 vials of ASV is administered 1-2 hours later if there is no improvement or worsening of symptoms(2,3). There is no justification for using 50 vials. I would also like to highlight the fact that the first dose of 10 vials of ASV is preferably given over 1 hour. There is no benefit in administering each dose over a longer period.

References

1. Jindal G, Mahajan V, Parmar VR. Antisnake venom in a neonate with snakebite. Indian Pediatr 2010; 47; 349-350

2. Simpson ID. The pediatric management of snakebite; the National protocol. Indian Pediatr 2007; 44: 173-176.

3. Handbook on Treatment Guidelines for Snake Bite and Scorpion Sting. Tamil Nadu Health Systems Project,Health and Family Welfare Department, Chennai: Government of Tamil Nadu, 2008.

 

Copyright© 1999 by the Indian Pediatrics (Disclaimer)